未找到相关数据
STUDY ABOUT ANTI-DEMENTIA DRUG USE IN PRIMARY CARE
被引：0
|作者：
Carracedo Martinez, Eduardo
[1
]
机构：
[1] SERGAS, Area Sanit Santiago de Compostela, Santiago De Compostela, A Coruna, Spain
来源：
ATENCION FARMACEUTICA
|
2009年
/
11卷
/
02期
关键词：
MEMANTINE;
CHOLINESTERASE INHIBITORS;
ALZHEIMER'S;
PRIMARY CARE;
ALZHEIMERS-DISEASE;
MEMANTINE TREATMENT;
CONTROLLED-TRIAL;
DEMENTIA;
MODERATE;
PREVALENCE;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Objectives: To perform a study about the use of memantine and cholinesterase inhibitors (donepezil, galantamine and rivastigmine) in primary care. Method: Cross-sectional 3-month study in five primary care units from the Santiago de Compostela (A Coruna) Healthcare Area. Results: The prevalence in the use of anti-dementia drugs is 0.36% with a 95% confidence interval (CI 95%) of 0.27% to 0.45%. No active principle is more used than the others. 96% of patients suffer from Alzheimer and 4% of Parkinson's-related dementia. 25% of these patients use memantine together with a cholinesterase inhibitor Conclusions: There is a widespread use of anti-dementia drugs even if the cognitive benefits are not yet considered as of clinical relevance. As well, the proportion of patients that use together these two anti-dementia drugs is high even if the efficacy of such association is under question.
引用
收藏
页码：124 / 126
页数：3
相关论文